Maglut Heavy Industries Raises $3.1M Pre-Seed

AusperBio

AusperBio is a near-commercial biopharmaceutical company with operations in the USA and China, dedicated to advancing oligonucleotide and targeted delivery technologies for transformative therapies, with an initial focus on achieving functional cure for CHB infection. The Company has established a diversified innovation engine built on its proprietary Med-Oligo™ ASO and Au-HALO™ targeted delivery technology and siRNA platforms, enabling the discovery and development of differentiated oligonucleotide therapeutics across multiple modalities. With multiple clinical-stage programs and a growing preclinical pipeline, AusperBio is advancing a backbone-based combination strategy toward a functional cure for HBV while expanding into additional disease areas with significant unmet medical needs.

REGENT

REGENT's mission is to drastically reduce the cost and headache of regional transportation between coastal destinations. We create Seaglider vessels, wing-in-ground-effect craft that fly just above the water's surface and couple the high speed of airplanes with the convenience of boats, all at the low cost of an all-electric system. The 12-passenger Viceroy Seaglider model will service routes up to 180 miles at 180 mph with existing battery technology, and routes up to 400 miles with next-gen batteries, all via existing dock infrastructure. Backed by the same investors who support SpaceX, Anduril, and Archer Aviation, our team of passionate, forward-thinking builders combines the best of aerospace and maritime expertise to turn zero-emission, high-speed coastal travel into reality.